Conference Coverage
Conference Coverage
FIDELIO-DKD: Finerenone cuts new-onset AFib in patients with type 2 diabetes and CKD
Conference Coverage
Dapagliflozin misses as treatment for COVID-19 but leaves intriguing signal for benefit
The SGLT2 inhibitor dapagliflozin was not associated with significant benefit in COVID-19 patients but came close.
Conference Coverage
Novel rehab program fights frailty, boosts capacity in advanced HF
The program, started in the hospital, worked on capabilities such as mobility, balance, and strength that would be necessary if exercises meant to...
Conference Coverage
Omics analysis links blood type to COVID-19
Conference Coverage
New STRENGTH analysis reignites debate on omega-3 CV benefits
The new analysis showing no benefits linked to higher achieved levels of EPA casts doubt over the use of high-dose omega-3 fatty acid products for...
Conference Coverage
Ultrasound renal denervation drops BP in patients on triple therapy
Conference Coverage
FLOWER-MI: FFR-guided complete revascularization shows no advantage in STEMI
In STEMI patients, event rates following complete revascularization guided by fractional flow reserve or angiography were similar.
Conference Coverage
Nasal spray resurrected after showing clinical benefits for PSVT
After missing its trial endpoint, etripamil, a treatment for paroxysmal supraventricular tachycardia, still appears beneficial.
Conference Coverage
LAAOS III: Surgical LAA closure cuts AFib stroke risk by one-third
The finding ‘opens a new paradigm’ for stroke prevention in atrial fibrillation and should change clinical guidelines, experts say.
Conference Coverage
ADAPTABLE: Low-dose aspirin as good as high-dose in CHD?
A large randomized trial specifically designed to investigate the optimum dose of aspirin in patients with established coronary disease has found...
Conference Coverage
PARADISE-MI: Sacubitril/valsartan can’t beat ramipril in patients with acute MI